Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer
Context. Radioiodine (RAI) administration has adverse effects in patients treated for thyroid cancer (DTC), but there is scarce information regarding their intensity and duration. Objective. To evaluate frequency and intensity of early and late RAI-related symptoms in patients with DTC. Design. Obse...
Saved in:
Main Authors: | Pablo Florenzano, Francisco J. Guarda, Rodrigo Jaimovich, Nicolás Droppelmann, Hernán González, José M. Domínguez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2016/2586512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early Sialadenitis After Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Prevalence and Predictors
by: Ruba Riachy, et al.
Published: (2020-01-01) -
Thyroid-Associated Ophthalmopathy after Radioactive Iodine Therapy for Metastatic Follicular Thyroid Carcinoma
by: Daisuke Murayama, et al.
Published: (2021-01-01) -
Durable Effect of Radioactive Iodine in a Patient with Metastatic Follicular Thyroid Carcinoma
by: Aubrey A. Carhill, et al.
Published: (2012-01-01) -
Analyzing Serum Level Changes in Dehydroepiandrosterone Sulfate, Dihydrotestosterone, Progesterone, and Prolactin after Radioactive Iodine Treatment for Papillary Thyroid Carcinoma
by: Mehrosadat Alavi, et al.
Published: (2024-07-01) -
Radiation Recall Dermatitis following Radioactive Iodine Therapy: A New Observation
by: Ikechukwu Chidobem, et al.
Published: (2021-01-01)